Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
06/10/2014 | US8748630 Process for preparing 2-amino-5-cyanobenzoic acid derivatives |
06/10/2014 | US8748623 Pyridinecarboxamides as CXCR2 modulators |
06/10/2014 | US8748619 Process for the resolution of omeprazole |
06/10/2014 | US8748618 Inhibitors of inv(16) leukemia |
06/10/2014 | US8748615 Process for the preparation of 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide |
06/10/2014 | US8748613 Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof |
06/10/2014 | US8748597 2,4-pyrimidinediamine compounds and their uses |
06/10/2014 | US8748596 Process for the preparation of histamine H3 receptor modulators |
06/10/2014 | US8748582 Affinity ligands and methods for protein purification |
06/10/2014 | US8748459 Pyridinoylpiperidines as 5-HT1F agonists |
06/10/2014 | US8748446 Halogenated compounds for photodynamic therapy |
06/10/2014 | US8748442 sGC stimulators |
06/10/2014 | US8748441 Therapeutic uses of quinazolinedione derivatives |
06/10/2014 | US8748440 Quinazolinone modulators of nuclear receptors |
06/10/2014 | US8748433 β3 adrenergic receptor agonists |
06/10/2014 | US8748432 Microbiocidal pyrazole derivatives |
06/10/2014 | US8748431 Microbicidal heterocycles |
06/10/2014 | US8748426 Inhibitors of diacylglycerol acyl transferase |
06/10/2014 | US8748424 Triazole compounds that modulate Hsp90 activity |
06/10/2014 | US8748340 Pesticidal compositions and processes related thereto |
06/10/2014 | CA2784799C Certain dipeptidyl peptidase inhibtors |
06/10/2014 | CA2764906C Gpr119 agonists |
06/10/2014 | CA2541509C Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
06/05/2014 | WO2014085528A1 Azaquinazoline carboxamide derivatives |
06/05/2014 | WO2014084410A1 Cyclohexanone compounds and herbicides comprising the same |
06/05/2014 | WO2014084330A1 Nitrogen-containing heterocyclic compound |
06/05/2014 | WO2014084323A1 Transparent electrode, and electronic device |
06/05/2014 | WO2014084170A1 Transparent electrode, electronic device, and organic electroluminescence element |
06/05/2014 | WO2014083571A1 A process for the preparation of alcaftadine |
06/05/2014 | WO2014083383A1 Substituted dihydropyrtoines for somatic embryogenesis iν plants |
06/05/2014 | WO2014083106A1 Process for preparing 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide |
06/05/2014 | WO2014082889A1 Novel imidazolines as dual inhibitors of mdm2 and mdmx |
06/05/2014 | WO2014082739A1 Substituted amino-arylcarboxamides as kcnq2/3 modulators |
06/05/2014 | WO2014082598A1 Inhibitors of bruton's tyrosine kinase |
06/05/2014 | WO2014082578A1 Heteroaryl alkyne compound and application thereof |
06/05/2014 | WO2014082381A1 Spiro ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof |
06/05/2014 | WO2014082379A1 Spiro ring compound as hepatitis c virus (hcv) inhibitor and uses thereof field of the invention |
06/05/2014 | WO2014025964A3 Salts and solid forms of (s)-3-(4-((4-morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same |
06/05/2014 | US20140155614 Pharmaceutical intermediates and process for the preparation thereof |
06/05/2014 | US20140155613 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
06/05/2014 | US20140155612 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
06/05/2014 | US20140155611 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
06/05/2014 | US20140155610 Preparation of pyridonecarboxylic acid antibacterials |
06/05/2014 | US20140155602 Arlethynyl Derivatives |
06/05/2014 | US20140155596 Cysteinyl leukotriene antagonists |
06/05/2014 | US20140155436 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
06/05/2014 | US20140155431 Modulators of atp-binding cassette transporters |
06/05/2014 | US20140155418 Receptor-Type Kinase Modulators and Methods of Use |
06/05/2014 | US20140155417 Compounds for modulating trpv3 function |
06/05/2014 | US20140155413 TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF |
06/05/2014 | US20140155410 Pyrazolylaminopyridines as inhibitors of fak |
06/05/2014 | US20140155408 Pyruvate kinase activators for use in therapy |
06/05/2014 | US20140155407 Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases |
06/05/2014 | US20140155404 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
06/05/2014 | US20140155402 Bi-heteroaryl compounds as vps34 inhibitors |
06/05/2014 | US20140155401 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands |
06/05/2014 | US20140155396 C-Met Modulators and Method of Use |
06/05/2014 | US20140155389 Bicyclic inhibitors of alk |
06/05/2014 | US20140155386 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
06/05/2014 | US20140155380 Salt and Crystalline Forms Thereof of a Drug |
06/05/2014 | US20140155378 c-Met Modulators and Method of Use |
06/05/2014 | US20140155377 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
06/05/2014 | US20140155374 Methods of using pyruvate kinase activators |
06/05/2014 | US20140155370 Nuclear transport modulators and uses thereof |
06/05/2014 | US20140155264 N-Thio-Anthranilamide Compounds and Their Use as Pesticides |
06/04/2014 | EP2738169A1 Oxazolidinone compounds and their uses in preparation of antibiotics |
06/04/2014 | EP2736920A1 Notch pathway signaling inhibitor compound |
06/04/2014 | EP2736900A1 Substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands |
06/04/2014 | EP2736899A1 Substituted bicyclic aromatic carboxamide and urea derivatives as vanilloid receptor ligands |
06/04/2014 | EP2736898A1 5ht1a antagonist useful for in vivo imaging |
06/04/2014 | EP2736897A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
06/04/2014 | EP2736896A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors |
06/04/2014 | EP2736895A1 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer |
06/04/2014 | EP2736887A1 Hydrazide containing nuclear transport modulators and uses thereof |
06/04/2014 | EP2736886A1 Substituted quinolines and their use as medicaments |
06/04/2014 | EP2736885A2 Cysteinyl leukotriene antagonists |
06/04/2014 | EP2736883A1 Nuclear transport modulators and uses thereof |
06/04/2014 | EP2736882A1 Substituted heterocyclic aza derivatives |
06/04/2014 | EP2736881A1 Process for producing n-(hetero)arylazoles |
06/04/2014 | EP2736514A1 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors |
06/04/2014 | CN1585772B Chemokine receptor antagonists and methods of use thereof |
06/04/2014 | CN103842357A Substituted heteroaromatic pyrazole-containing carboxamide and urea compounds as vanilloid receptor ligands |
06/04/2014 | CN103842356A 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases |
06/04/2014 | CN103842355A Metalloenzyme inhibitor compounds |
06/04/2014 | CN103842354A Anthranilamide compounds and their use as pesticides |
06/04/2014 | CN103842353A Pyridines compounds as inhibitors of kinase |
06/04/2014 | CN103842344A Cystelinyl leukotriene antagonists based on quinolin, quinoxaline or benz[c]thiazole |
06/04/2014 | CN103842342A Anthranilamide compounds and their use as pesticides |
06/04/2014 | CN103842340A Nuclear transport modulators and uses thereof |
06/04/2014 | CN103842336A Aniline type compounds |
06/04/2014 | CN103833756A Pyridazinone compound as well as preparation method and application thereof |
06/04/2014 | CN103833732A Emitting compound and organic light emitting diode device using the same |
06/04/2014 | CN103833731A New preparation method for chiral sulfoxide compound and its salt, and crystal form |
06/04/2014 | CN103833730A Benzo five-membered nitrogen-containing heterocycle-based piperazine derivative and preparation method as well as application thereof |
06/04/2014 | CN103833729A Method using visible light catalyzed cross-coupling reaction to prepare coupling product and release hydrogen |
06/04/2014 | CN103833658A Benzotriazole-based piperazine compound as well as preparation method and pharmaceutical composition thereof |
06/04/2014 | CN103833646A Fatty amino substituted quinazolinone derivative and preparation method and application thereof |
06/04/2014 | CN103833643A Benzimidazolyl-piperazine compound and preparation method and pharmaceutical composition thereof |
06/04/2014 | CN103833642A Application of benzo five-membered nitrogen-containing heterocycle-based piperazine derivative |
06/04/2014 | CN103833544A 11-beta-hydroxysteroid dehydrogenase type i inhibitors |